cas 2215028-64-9|| where to buy 6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

Product Name:6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyrazine

Packing Unit	Available Stock	Price($)
CM479274-1g	in stock	Ǌůƥ
CM479274-5g	in stock	ŹƓĽŗ
CM479274-10g	in stock	ƓŗǤů

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2215028-64-9 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:2215028-64-9; Molecular Formula:C10H10ClIN4O; Melting Point:-; Smiles Code:ClC1=CN=C2C(I)=NN(C3CCCCO3)C2=N1; Density:

: Catalog Number:CM479274; Molecular Weight:364.57; Boiling Point:; MDL No:MFCD32220431; Storage:

: Pyrazolopyrazines; The pyrazolopyrazine ring system is a very interesting class of heterocyclic compounds considered as important scaffolds for many effective bioactive agents with low toxicity, antioxidant, anticonvulsant, antiparasitic, anti-inflammatory, antiviral, antibacterial, anti- Fungal and analgesic activity.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.